These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15510186

  • 1. Sexual function after permanent 125I-brachytherapy for prostate cancer.
    Mabjeesh N, Chen J, Beri A, Stenger A, Matzkin H.
    Int J Impot Res; 2005; 17(1):96-101. PubMed ID: 15510186
    [Abstract] [Full Text] [Related]

  • 2. Erectile function after brachytherapy with external beam radiation for prostate cancer.
    Fujioka H, Ishimura T, Sakai Y, Fujii T, Jo Y, Takenaka A, Fujisawa M.
    Arch Androl; 2004; 50(4):295-301. PubMed ID: 15277008
    [Abstract] [Full Text] [Related]

  • 3. The effect on erectile function of 103palladium implantation for localized prostate cancer.
    Ponholzer A, Oismüller R, Somay C, Büchler F, Maier U, Hawliczek R, Rauchenwald M, Madersbacher S.
    BJU Int; 2005 Apr; 95(6):847-50. PubMed ID: 15794796
    [Abstract] [Full Text] [Related]

  • 4. Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up.
    Cesaretti JA, Kao J, Stone NN, Stock RG.
    BJU Int; 2007 Aug; 100(2):362-7. PubMed ID: 17617140
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE, Ohebshalom M, Mohideen N, Mulhall JP.
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [Abstract] [Full Text] [Related]

  • 6. The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.
    Ohebshalom M, Parker M, Guhring P, Mulhall JP.
    J Urol; 2005 Jul; 174(1):258-62; discussion 262. PubMed ID: 15947650
    [Abstract] [Full Text] [Related]

  • 7. Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer.
    Huyghe E, Delannes M, Wagner F, Delaunay B, Nohra J, Thoulouzan M, Shut-Yee JY, Plante P, Soulie M, Thonneau P, Bachaud JM.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):126-32. PubMed ID: 19362236
    [Abstract] [Full Text] [Related]

  • 8. Erectile function durability following permanent prostate brachytherapy.
    Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Anderson R, Lief JH.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):639-48. PubMed ID: 19303721
    [Abstract] [Full Text] [Related]

  • 9. [Orgasm after curietherapy with permanent iodine-125 radioimplants for localized prostate cancer].
    Delaunay B, Delannes M, Salloum A, Delavierre D, Wagner F, Jonca F, Thoulouzan M, Plante P, Bachaud JM, Soulie M, Huyghe E.
    Prog Urol; 2011 Dec 01; 21(13):932-9. PubMed ID: 22118358
    [Abstract] [Full Text] [Related]

  • 10. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S, Cesaretti J, Stone NN, Stock RG.
    BJU Int; 2006 Nov 01; 98(5):979-81. PubMed ID: 17034599
    [Abstract] [Full Text] [Related]

  • 11. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function.
    Schiff JD, Bar-Chama N, Cesaretti J, Stock R.
    BJU Int; 2006 Dec 01; 98(6):1255-8. PubMed ID: 17125483
    [Abstract] [Full Text] [Related]

  • 12. Segmental dosimetry, toxicity and long-term outcome in patients with prostate cancer treated with permanent seed implants.
    Meyer A, Wassermann J, Warszawski-Baumann A, Baumann R, Machtens S, Karstens JH, Christiansen H, Merseburger A, Kuczyk MA, von Klot C.
    BJU Int; 2013 May 01; 111(6):897-904. PubMed ID: 23305079
    [Abstract] [Full Text] [Related]

  • 13. Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05.
    Feigenberg SJ, Lee WR, Desilvio ML, Winter K, Pisansky TM, Bruner DW, Lawton C, Morton G, Baikadi M, Sandler H.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):956-64. PubMed ID: 15989995
    [Abstract] [Full Text] [Related]

  • 14. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB, Bissonette EA, Theodorescu D.
    BJU Int; 2004 Nov 15; 94(7):1003-9. PubMed ID: 15541117
    [Abstract] [Full Text] [Related]

  • 15. Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.
    Zagar TM, Stock RG, Cesaretti JA, Stone NN.
    Brachytherapy; 2007 Nov 15; 6(1):26-33. PubMed ID: 17284382
    [Abstract] [Full Text] [Related]

  • 16. Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds.
    Bottomley D, Ash D, Al-Qaisieh B, Carey B, Joseph J, St Clair S, Gould K.
    Radiother Oncol; 2007 Jan 15; 82(1):46-9. PubMed ID: 17161481
    [Abstract] [Full Text] [Related]

  • 17. [The chronological process of erectile function after low-dose rate prostate brachytherapy for localised prostate cancer].
    Bannowsky A, Bäurle L, Ataniyasov R, Ahlen Hv, Loch T.
    Aktuelle Urol; 2011 Jul 15; 42(4):252-5. PubMed ID: 21769761
    [Abstract] [Full Text] [Related]

  • 18. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer.
    Stock RG, Kao J, Stone NN.
    J Urol; 2001 Feb 15; 165(2):436-9. PubMed ID: 11176391
    [Abstract] [Full Text] [Related]

  • 19. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan V, Morris WJ.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):155-63. PubMed ID: 16111584
    [Abstract] [Full Text] [Related]

  • 20. Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer.
    Pinkawa M, Fischedick K, Gagel B, Piroth MD, Borchers H, Jakse G, Eble MJ.
    Urology; 2006 Jul 01; 68(1):104-9. PubMed ID: 16806434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.